Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on August 4, 2025
Alligator Alcatraz: U.S. Politics Today Report Probes Florida’s Controversial Immigration Site
EIN Presswire
·
August 4, 2025
USPT interviews state Sen. Shevrin Jones about his visit to the remote detention center WASHINGTON, DC, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- U.S. Politics Today (USPT), an independent Substack publication offering European-informed …
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
GlobeNewswire
·
August 4, 2025
- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a …
Call for Submissions: 'Moons, Castles, Trees' Exhibition Joins The Wrong Biennale 2025/26
EIN Presswire
·
August 4, 2025
Open art call: Submit to Moons, Castles, Trees for The Wrong Biennale '25/26 via Chronotopes. Explore AI in art. Free entry. Deadline: Sept 15, 2025. COPENHAGEN, DENMARK, August 4, 2025 /EINPresswire.com/ -- Submissions are now open for “Moons, Castles, …
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 4, 2025
DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it issued grants of employment inducement awards to Anshul Thakral, the Company’s recently …
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 4, 2025
MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
GlobeNewswire
·
August 4, 2025
LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which has been has granted …
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
GlobeNewswire
·
August 4, 2025
Cellectis to host an Investor R…
Cellectis publie ses résultats financiers du deuxième trimestre 2025 et une mise à jour de ses activités
GlobeNewswire
·
August 4, 2025
Cellectis organise un R…
Ardelyx Announces Changes to the Executive Leadership Team
GlobeNewswire
·
August 4, 2025
Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
August 4, 2025
FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 4, 2025
Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million …
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
GlobeNewswire
·
August 4, 2025
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to manage …
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
GlobeNewswire
·
August 4, 2025
Woburn, MA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc., (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the …
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
GlobeNewswire
·
August 4, 2025
Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Transplant Pancreatic …
Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction
GlobeNewswire
·
August 4, 2025
www.freyapharmasolutions.com Study evaluates Lybrido™’s Dual-Action therapy for Female Sexual Dysfunction Innovative clitoral blood flow measurement technique aims to objectively quantify treatment efficacy of two dose-combinations ALETTA Pivotal Study …
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
GlobeNewswire
·
August 4, 2025
Primary focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates positive signs of both no significant toxicity and superior PFS and …
Critical Metals Corp CRML NASDAQ – Announces Exceptionally High Grades of both Gallium & Rare Earth Elements Results at its Tanbreez Project in Greenland
GlobeNewswire
·
August 4, 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to report outstanding assay results from recent as well as historical diamond …
Greenpeace MENA:Notre région a tout à gagner des négociations sur le traité mondial contre la pollution plastique
EIN Presswire
·
August 4, 2025
BEYROUTH, LEBANON, August 4, 2025 /EINPresswire.com/ -- Alors que le regard du monde entier se tourne vers Genève pour le dernier, décisif cycle de négociations sur le Traité mondial contre la pollution plastique (INC5.2), du 5 au 14 août, Greenpeace …
Greenpeace MENA: Historical Chance for Leaders to Push for a Strong Global Plastics Treaty
EIN Presswire
·
August 4, 2025
BEIRUT, LEBANON, August 4, 2025 /EINPresswire.com/ -- As the world’s eyes turn to Geneva for the final and most critical round of negotiations on the Global Plastics Treaty (INC5.2) from August 5 to 14, Greenpeace Middle East and North Africa (MENA) is …
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 4, 2025
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency from baseline, with 22% at 100% seizure reduction in last 28 days Initiated two registrational studies for …